1
/
of
1
Breast Cancer Facts, Myths, and Controversies: Understanding Current Screenings and Treatments - Hardcover
Breast Cancer Facts, Myths, and Controversies: Understanding Current Screenings and Treatments - Hardcover
Regular price
$111.15 USD
Regular price
Sale price
$111.15 USD
Quantity
Couldn't load pickup availability
by Madelon Finkel (Author)
This book, written for the layperson, provides evidence-based material explaining the complex and evolving evidence of the benefits and limitations of breast cancer screening and the advances in breast cancer treatment.
A diagnosis of breast cancer is one of the most emotionally charged statements a woman can hear from her doctor. Understanding the rapid changes in breast cancer diagnosis and treatment is challenging, especially for those without a medical background. This book will help explain the strengths and weaknesses of breast cancer screening, breast cancer treatment, and ways of coping with the disease (for oneself or a loved one). Written for the layperson, this text explains the history of disease prevention with a specific emphasis on breast cancer detection and treatment. The main chapters weigh the pros and cons of well-known but often mystifying screening tests, such as mammograms; discuss the benefits and side effects of targeted hormone therapies; consider holistic regimens that complement traditional medicine; and explore the mental, physical, and emotional strain caused by breast cancer. Concluding with the current breast cancer screening guidelines recommended by leading organizations in disease prevention, Breast Cancer Facts, Myths, and Controversies not only engages with the history of breast cancer screening, diagnosis, and treatment, it looks ahead to a brighter future for survivors.Author Biography
Madelon L. Finkel, PhD, is professor of population health sciences and director of the Office of Global Health Education at Weill Cornell Medicine in New York City.
Number of Pages: 264
Dimensions: 1 x 9.3 x 6.1 IN
Publication Date: July 31, 2021
